Dr. Shook has been with Nkarta since 2020 as a medical director and was appointed vice president of clinical affairs in May 2022, according to LinkedIn. He also practices as a pediatric oncologist and transplant physician.
Prior to joining Nkarta, Dr. Shook was a fellow, fellowship director and faculty member at St. Jude’s Research Hospital in Memphis, Tenn., according to a Jan. 9 release announcing his promotion.
Dr. Shook has also developed and led a variety of first-in-human cell therapy clinical trials, including one focusing on the use of CD19 CAR-NK cells. He has also conducted research with Dario Campana, MD, PhD, Nkarta’s scientific founder.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
